Austar Lifesciences Limited
AULSF
$0.07
$0.0651,300.00%
OTC PK
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -0.48% | 15.38% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -0.48% | 15.38% | |||
| Cost of Revenue | -0.48% | 17.21% | |||
| Gross Profit | -0.48% | 8.38% | |||
| SG&A Expenses | -0.48% | 12.96% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 0.48% | -44.16% | |||
| Total Operating Expenses | -0.48% | 16.51% | |||
| Operating Income | -0.49% | -23.61% | |||
| Income Before Tax | -0.48% | 31.97% | |||
| Income Tax Expenses | -0.50% | -47.30% | |||
| Earnings from Continuing Operations | -0.47% | 126.59% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -0.52% | -50.94% | |||
| Net Income | -0.48% | 75.58% | |||
| EBIT | -0.49% | -23.61% | |||
| EBITDA | -0.48% | -5.82% | |||
| EPS Basic | 0.00% | 75.00% | |||
| Normalized Basic EPS | 0.00% | -30.00% | |||
| EPS Diluted | 0.00% | 75.00% | |||
| Normalized Diluted EPS | 0.00% | -30.00% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||